Avecho Biotechnology Investor Briefing – 8 December
Avecho Biotechnology (ASX: AVE) Webcast Replay
Avecho Biotechnology (ASX: AVE) is a pharma innovator offering a world-first drug delivery platform used in the projected US$55 billion cannabidiol market.
As a part of our ‘The Insiders: Meet the CEOs’ series, CEO Dr Paul Gavin, provides valuable insights to the company, its key markets and industry, and future prospects.
Recorded on 8th December 2021 at 12pm (AEDT).